All Type of News
Drug wholesalers to bring fight to Constitutional Court
The debate over regulating the warehouse size of new wholesalers to 264 square meters will be brought to the Constitutional Court against a revision bill of Pharmaceutical Affairs Law passed last March.
In a semina...
Ethical sales drop 8.5% in May
The domestic ethical market for outpatients in May accounted for 708.9 billion won, showing an 8.5-percent decrease over the same period of last year and reflecting the lack of blockbusters' launching and the governme...
UBcare buys 60% stake in PlatinumMD
UBcare Co., a leading healthcare solution company in Korea, has struck a strategic partnership with its U.S.-based PlatinumMD.
UBcare said on last Thursday that it has bought a 60 percent stake in PlatinumMD to tak...
Does non-selection of innovative pharmaceutical firms hurt pride of multinational drug companies?
When the government announced a list of 43 innovative pharmaceutical firms including Otsuka Korea on Monday, the KRPIA has expressed its deep regret over the government’s failure to include their other nine candidates...
People should not fear groundless information on DRG system
The government is making all-outs to let the public have proper information on a “diagnosis-related group” payment plan as incongruous information is circulating through social network services, said an official from ...
Reference pricing for drugs: Is it compatible with Korean health care system?
- This article analyzes the impact of the reference pricing (RP) system on the Korea’s health insurance scheme, which has been recently reported to the Ministry of Health and Welfare by the Korea Drug Research Associa...
Twynstar showing robust sales in May
Boehringer Ingelheim’s antihypertensive Twynstar has expand a bigger market share at the brisk pace as its sales in May stood at 4.8 billion won, according to Yakup.com, a pharmaceutical information provider. The drug...
Green Cross eying sales of 10 billion won with new drug
Green Cross Corporation one of Korea's largest pharmaceutical companies said Thursday that its Shinbaro capsule, a new natural substance-containing medicine designed to cure degenerative arthritis, is expected to reac...
Government-certified innovative pharmaceutical firms need to be reborn as research oriented ones
The government has recently selected 43 drug makers as innovative pharmaceutical firms to foster global pharmaceutical firms through the creation of a large-scale R&D fund and offering various tax benefits to local co...
KRPIA regrets government’s boycott of innovative pharmaceutical firms
The Korean Research-based Pharmaceutical Industry Association (KRPIA) on Wednesday expressed regret at the government’s non-selection of many multinational firms here as innovative pharmaceutical firms, although 10 fo...
